Westlake Chemical Partners LP logo

Westlake Chemical Partners LP

WLKP

NYSEBasic MaterialsChemicals

Previous close

$21.56

+$0.03 · +0.14%

Aug 21, 4:00 PM ET

WLKP company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

100

Deep Value

Momentum

47

Neutral

Sentiment

52

Mixed

Risk resilience

80

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into ethylene. Furthermore, the partnership distributes a range of chemical co-products—such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen—directly to external buyers, conducting these sales through either immediate spot transactions or established contractual agreements. Westlake Chemical Partners GP LLC serves as the entity's general partner. The company was founded in 2014 and its corporate headquarters are located in Houston, Texas.

Industry
Chemicals
Sector
Basic Materials
Headquarters
US
CEO
Jean-Marc Gilson
Listed since
Jul 30, 2014
Employees
2,169

Market position

Day range

Current $21.56

52-week range

Current $21.56

Open
$21.44
Previous close
$21.53
Volume
27.26K
0.89× average
Average volume
30.48K
Average daily volume
Market cap
759.9M USD
Beta
0.51
Market reference 1
50-day average
$22.094
-2.42% below average
200-day average
$21.4124
+0.69% above average

Financials

Financial snapshot

Latest / TTM

Financial health

Altman Z-score
3.11
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%27%14%1%Gross margin, FY2021: 36.36%Gross margin, FY2022: 23.69%Gross margin, FY2023: 32.54%Gross margin, FY2024: 36.88%Gross margin, FY2025: 29.81%Operating margin, FY2021: 33.81%Operating margin, FY2022: 21.82%Operating margin, FY2023: 30.04%Operating margin, FY2024: 34.37%Operating margin, FY2025: 27.39%Net margin, FY2021: 6.79%Net margin, FY2022: 4.03%Net margin, FY2023: 4.56%Net margin, FY2024: 5.49%Net margin, FY2025: 4.17%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 36.36%. Gross margin FY2022 23.69%. Gross margin FY2023 32.54%. Gross margin FY2024 36.88%. Gross margin FY2025 29.81%. Operating margin FY2021 33.81%. Operating margin FY2022 21.82%. Operating margin FY2023 30.04%. Operating margin FY2024 34.37%. Operating margin FY2025 27.39%. Net margin FY2021 6.79%. Net margin FY2022 4.03%. Net margin FY2023 4.56%. Net margin FY2024 5.49%. Net margin FY2025 4.17%.

Income trends

Revenue

1.17B USD+2.71%

Operating income

319.58M USD-18.15%

Net income

48.7M USD-21.95%
Income trends across reported periods1.75B USD1.13B USD512.03M USD−105.75M USDRevenue, FY2021: 1.21B USDRevenue, FY2022: 1.59B USDRevenue, FY2023: 1.19B USDRevenue, FY2024: 1.14B USDRevenue, FY2025: 1.17B USDOperating income, FY2021: 410.69M USDOperating income, FY2022: 347.69M USDOperating income, FY2023: 357.71M USDOperating income, FY2024: 390.44M USDOperating income, FY2025: 319.58M USDNet income, FY2021: 82.55M USDNet income, FY2022: 64.17M USDNet income, FY2023: 54.28M USDNet income, FY2024: 62.39M USDNet income, FY2025: 48.7M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.21B USD. Revenue FY2022 1.59B USD. Revenue FY2023 1.19B USD. Revenue FY2024 1.14B USD. Revenue FY2025 1.17B USD. Operating income FY2021 410.69M USD. Operating income FY2022 347.69M USD. Operating income FY2023 357.71M USD. Operating income FY2024 390.44M USD. Operating income FY2025 319.58M USD. Net income FY2021 82.55M USD. Net income FY2022 64.17M USD. Net income FY2023 54.28M USD. Net income FY2024 62.39M USD. Net income FY2025 48.7M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.17B USD1.14B USD1.19B USD1.59B USD1.21B USD
Cost of goods sold818.85M USD716.96M USD803.33M USD1.22B USD773.15M USD
Gross profit347.85M USD418.94M USD387.46M USD377.37M USD441.71M USD
Selling, general, and administrative28.27M USD28.5M USD29.75M USD29.68M USD31.02M USD
Operating expenses28.27M USD28.5M USD29.75M USD29.68M USD31.02M USD
Interest expense22.9M USD25.7M USD26.5M USD13.41M USD8.82M USD
Depreciation and amortization127.98M USD111.9M USD110.2M USD121.07M USD108.81M USD
Operating income319.58M USD390.44M USD357.71M USD347.69M USD410.69M USD
Net income48.7M USD62.39M USD54.28M USD64.17M USD82.55M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
27%
3 beats, 8 misses, 0 met estimates
Average EPS surprise
-4.53%
11 comparable reports
Latest EPS result
0.4
Estimate 0.41 · Miss by 2.44%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.710.510.320.12Q1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 24, 2025: actual 0.43, estimate 0.36, surprise +19.44%, Beat. Q2 2025, reported May 2, 2025: actual 0.14, estimate 0.38, surprise -63.16%, Miss. Q3 2025, reported Aug 5, 2025: actual 0.41, estimate 0.444, surprise -7.72%, Miss. Q4 2025, reported Oct 30, 2025: actual 0.42, estimate 0.43, surprise -2.33%, Miss. Q1 2026, reported Feb 24, 2026: actual 0.41, estimate 0.379, surprise +8.18%, Beat. Q2 2026, reported May 5, 2026: actual 0.4, estimate 0.43, surprise -6.98%, Miss. Q3 2026, reported Aug 4, 2026: actual 0.4, estimate 0.41, surprise -2.44%, Miss. Q4 2026, reported Oct 29, 2026: actual —, estimate 0.67, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates560.95M445.19M329.44M213.68MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 24, 2025: actual 290.06M USD, estimate 262M USD, surprise +10.71%, Beat. Q2 2025, reported May 2, 2025: actual 237.63M USD, estimate 296M USD, surprise -19.72%, Miss. Q3 2025, reported Aug 5, 2025: actual 297.12M USD, estimate 301M USD, surprise -1.29%, Miss. Q4 2025, reported Oct 30, 2025: actual 308.9M USD, estimate 303M USD, surprise +1.95%, Beat. Q1 2026, reported Feb 24, 2026: actual 323.05M USD, estimate 313M USD, surprise +3.21%, Beat. Q2 2026, reported May 5, 2026: actual 305.68M USD, estimate 522M USD, surprise -41.44%, Miss. Q3 2026, reported Aug 4, 2026: actual 297.1M USD, estimate 537M USD, surprise -44.67%, Miss. Q4 2026, reported Oct 29, 2026: actual —, estimate 367M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$29.00

34.51% upside
Past 12 months12-month forecastHigh $29.00Average $29.00Low $29.00

Rating distribution

10 ratings
Strong buy00%
Buy330%
Hold770%
Sell00%
Strong sell00%

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.8856

2025 complete year0.0% since 2021

2026 partial: $1.4142

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Aug 13, 2026

$0.4714

Quarterly

Record Aug 13, 2026 · Payment Aug 28, 2026

Dividend

Ex-dividend May 14, 2026

$0.4714

Quarterly

Record May 14, 2026 · Payment Jun 1, 2026

Dividend

Ex-dividend Feb 6, 2026

$0.4714

Quarterly

Record Feb 6, 2026 · Payment Feb 23, 2026

Dividend

Ex-dividend Nov 10, 2025

$0.4714

Quarterly

Record Nov 10, 2025 · Payment Nov 26, 2025

Dividend

Ex-dividend Aug 12, 2025

$0.4714

Quarterly

Record Aug 12, 2025 · Payment Aug 27, 2025

Dividend

Ex-dividend May 13, 2025

$0.4714

Quarterly

Record May 13, 2025 · Payment May 29, 2025

WLKP peers

ETFs holding WLKP

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research WLKP

research.disclaimer